Abstract
Lipoprotein lipase (LPL) is bound to heparan sulphate proteoglycans (HSPG) at the luminal surface of endothelium. It is the key enzyme involved in the hydrolysis of very low density lipoproteins (VLDL). Prior to lipolysis by LPL, the lipoproteins are considered to interact with vessel wall HSPG. Apolipoprotein (apo) E is thought to mediate this interaction thereby enhancing the stability of the lipoprotein-LPL complex. We hypothesize that apo E mutations may cause a diminished interaction of VLDL with HSPG leading to impaired lipolysis of VLDL by HSPG-bound LPL. In order to test this hypothesis, lipolysis experiments were performed using HSPG-bound LPL. The mean lipolysis rates of VLDL, isolated from the apo E2 (Lys146-->Gln) heterozygotes, apo E2 (Arg158-->Cys) homozygotes and apo E3-Leiden heterozygotes were 92.3 +/- 10.3 (ns), 77.3 +/- 4.2 (P < 0.05) and 76.7 +/- 10.0% (P < 0.05), respectively, of that of control VLDL (100.0 +/- 9.7%). No differences in lipolysis were observed between VLDL from controls and VLDL from the same patients if LPL in solution was used. Thus, compositional differences alone can not explain the differences in lipolysis rates observed with HSPG-bound LPL. In competition experiments, the binding effic...Continue Reading
References
Jun 4, 1977·Lancet·A ChaitW R Hazzard
May 12, 1975·Analytical Biochemistry·T G RedgraveC E West
Oct 13, 1977·Nature·G UtermannA Steinmetz
Sep 22, 1992·Biochimica Et Biophysica Acta·K MoriyamaK Arakawa
Sep 22, 1992·Biochimica Et Biophysica Acta·M S LiuJ D Brunzell
Oct 16, 1992·Science·S H ZhangN Maeda
Jun 15, 1992·Biochemical and Biophysical Research Communications·M MulderL M Havekes
Aug 1, 1991·The Journal of Clinical Investigation·P de KnijffL M Havekes
Sep 14, 1989·Nature·U BeisiegelK K Stanley
Feb 21, 1972·Biochimica Et Biophysica Acta·D W BilheimerR I Levy
Aug 15, 1970·Nature·U K Laemmli
Oct 1, 1981·The Journal of Clinical Investigation·W J SchneiderR W Mahley
Aug 1, 1995·The Journal of Clinical Investigation·W A MannH B Brewer
Jan 1, 1994·Human Mutation·P de KnijffL M Havekes
Sep 1, 1994·The Journal of Clinical Investigation·P de KnijffL M Havekes
Oct 1, 1995·Current Opinion in Lipidology·G Olivecrona, T Olivecrona
Mar 1, 1996·The Journal of Clinical Investigation·B J van VlijmenL M Havekes
Jun 21, 1996·The Journal of Biological Chemistry·P C Rensen, T J van Berkel
Mar 1, 1996·The Biochemical Journal·W L HendriksL M Havekes
Aug 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·M C JongL M Havekes
Aug 2, 1996·Atherosclerosis·M J HofferG R Thompson
Nov 29, 1996·The Journal of Biological Chemistry·B J van VlijmenL M Havekes
Citations
Jun 28, 2001·Atherosclerosis·F M van BockxmeerR Taylor
Nov 13, 2003·Atherosclerosis·Katherine CianfloneBrian M Gilfix
Jul 31, 1999·Atherosclerosis·W A MannU Beisiegel
Jun 5, 2003·Biochimica Et Biophysica Acta·Mayumi YamamotoTetsurou Handa
Feb 12, 2008·Journal of Lipid Research·Gery GerritsenKo Willems van Dijk
May 7, 2009·Journal of Lipid Research·Jean-Paul Pais de BarrosLaurent Lagrost
Aug 25, 2011·Journal of Lipid Research·Sebastiano CalandraCarol C Shoulders
Dec 21, 2000·Current Atherosclerosis Reports·K W van DijkL M Havekes
Aug 2, 2007·Kidney International·G DautinD Masson
Jul 18, 2006·Atherosclerosis·Richard L SeipPaul D Thompson
Dec 17, 2010·Atherosclerosis·D EvansF U Beil
Oct 7, 2004·Journal of Lipid Research·Sung-Joon LeeAllen D Cooper
Nov 22, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Julien A MenardMattias Belting
Jul 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·F de BeerL M Havekes
Apr 13, 2021·Frontiers in Oncology·Vasileios LazarisKyriakos E Kypreos
Jul 15, 2006·Metabolism: Clinical and Experimental·Masumi HaraKazuhisa Tsukamoto